Concepts (154)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Schizophrenia | 22 | 2022 | 326 | 7.260 |
Why?
|
| Antipsychotic Agents | 9 | 2022 | 364 | 2.800 |
Why?
|
| Psychotic Disorders | 6 | 2022 | 149 | 2.690 |
Why?
|
| Clozapine | 2 | 2022 | 24 | 1.450 |
Why?
|
| Suicide, Attempted | 6 | 2022 | 148 | 1.390 |
Why?
|
| Marijuana Abuse | 3 | 2019 | 48 | 1.150 |
Why?
|
| Toxoplasmosis | 4 | 2016 | 22 | 1.020 |
Why?
|
| Kynurenine | 2 | 2016 | 24 | 0.960 |
Why?
|
| Bipolar Disorder | 6 | 2019 | 311 | 0.940 |
Why?
|
| Schizophrenic Psychology | 6 | 2018 | 82 | 0.920 |
Why?
|
| Gliadin | 2 | 2016 | 3 | 0.890 |
Why?
|
| S100 Calcium Binding Protein beta Subunit | 2 | 2021 | 15 | 0.730 |
Why?
|
| Veterans | 2 | 2022 | 1792 | 0.640 |
Why?
|
| Interleukin-6 | 1 | 2021 | 414 | 0.610 |
Why?
|
| C-Reactive Protein | 2 | 2019 | 450 | 0.590 |
Why?
|
| Cholesterol, HDL | 1 | 2019 | 394 | 0.520 |
Why?
|
| L-Selectin | 1 | 2017 | 18 | 0.520 |
Why?
|
| Marijuana Smoking | 1 | 2016 | 31 | 0.500 |
Why?
|
| Tryptophan | 1 | 2016 | 82 | 0.490 |
Why?
|
| Cocaine-Related Disorders | 2 | 2015 | 205 | 0.480 |
Why?
|
| Triglycerides | 1 | 2019 | 605 | 0.480 |
Why?
|
| Dyslipidemias | 1 | 2019 | 251 | 0.470 |
Why?
|
| Overweight | 1 | 2019 | 379 | 0.470 |
Why?
|
| Immunoglobulin G | 2 | 2016 | 790 | 0.470 |
Why?
|
| Body Mass Index | 2 | 2019 | 1683 | 0.460 |
Why?
|
| Length of Stay | 3 | 2019 | 1393 | 0.460 |
Why?
|
| Toxoplasma | 2 | 2012 | 18 | 0.440 |
Why?
|
| Affective Symptoms | 1 | 2015 | 63 | 0.440 |
Why?
|
| Mood Disorders | 2 | 2018 | 125 | 0.440 |
Why?
|
| GTP Cyclohydrolase | 1 | 2014 | 7 | 0.420 |
Why?
|
| Adult | 20 | 2021 | 31122 | 0.410 |
Why?
|
| Phenylalanine | 1 | 2014 | 130 | 0.400 |
Why?
|
| Cognitive Dysfunction | 1 | 2018 | 336 | 0.390 |
Why?
|
| Hospitals, Psychiatric | 3 | 2018 | 70 | 0.390 |
Why?
|
| Male | 26 | 2021 | 64506 | 0.370 |
Why?
|
| Middle Aged | 18 | 2021 | 28393 | 0.370 |
Why?
|
| Cognition | 2 | 2017 | 813 | 0.350 |
Why?
|
| Medication Adherence | 1 | 2015 | 332 | 0.350 |
Why?
|
| Female | 26 | 2021 | 70349 | 0.350 |
Why?
|
| Inflammation | 1 | 2019 | 1480 | 0.350 |
Why?
|
| Antibodies, Protozoan | 1 | 2011 | 101 | 0.340 |
Why?
|
| Smoking | 2 | 2013 | 929 | 0.330 |
Why?
|
| Coronavirus | 1 | 2010 | 27 | 0.330 |
Why?
|
| Hypercholesterolemia | 1 | 2013 | 234 | 0.320 |
Why?
|
| Influenza B virus | 1 | 2010 | 102 | 0.320 |
Why?
|
| Humans | 36 | 2022 | 130444 | 0.310 |
Why?
|
| Autoantibodies | 1 | 2013 | 439 | 0.310 |
Why?
|
| Influenza A virus | 1 | 2010 | 142 | 0.310 |
Why?
|
| Cognition Disorders | 2 | 2014 | 556 | 0.300 |
Why?
|
| Case-Control Studies | 4 | 2021 | 3407 | 0.260 |
Why?
|
| Coronavirus Infections | 1 | 2010 | 363 | 0.230 |
Why?
|
| Young Adult | 7 | 2019 | 9975 | 0.230 |
Why?
|
| Aging | 1 | 2013 | 1252 | 0.220 |
Why?
|
| Substance Abuse Detection | 2 | 2015 | 40 | 0.220 |
Why?
|
| Suicidal Ideation | 3 | 2019 | 245 | 0.220 |
Why?
|
| Comorbidity | 3 | 2019 | 1587 | 0.210 |
Why?
|
| Influenza, Human | 1 | 2010 | 700 | 0.210 |
Why?
|
| Hypertension | 1 | 2013 | 1354 | 0.210 |
Why?
|
| Cocaine | 2 | 2015 | 209 | 0.200 |
Why?
|
| Self-Injurious Behavior | 2 | 2015 | 64 | 0.200 |
Why?
|
| Linear Models | 2 | 2016 | 689 | 0.190 |
Why?
|
| Suicide | 2 | 2019 | 198 | 0.190 |
Why?
|
| Odds Ratio | 3 | 2016 | 1222 | 0.190 |
Why?
|
| Violence | 2 | 2013 | 127 | 0.180 |
Why?
|
| Neuropsychological Tests | 2 | 2017 | 955 | 0.170 |
Why?
|
| P-Selectin | 1 | 2021 | 69 | 0.170 |
Why?
|
| Cannabinoids | 2 | 2019 | 32 | 0.170 |
Why?
|
| Psychiatric Status Rating Scales | 4 | 2017 | 828 | 0.160 |
Why?
|
| Cross-Sectional Studies | 3 | 2021 | 3803 | 0.160 |
Why?
|
| Patient Admission | 2 | 2018 | 184 | 0.150 |
Why?
|
| Biomarkers | 2 | 2021 | 3396 | 0.140 |
Why?
|
| Safety-net Providers | 1 | 2018 | 87 | 0.130 |
Why?
|
| Pilot Projects | 1 | 2021 | 1451 | 0.130 |
Why?
|
| Antipyretics | 1 | 2016 | 7 | 0.130 |
Why?
|
| Psychomotor Agitation | 1 | 2016 | 54 | 0.120 |
Why?
|
| Patient Discharge | 2 | 2019 | 508 | 0.120 |
Why?
|
| Delirium | 1 | 2017 | 65 | 0.120 |
Why?
|
| Obesity | 2 | 2019 | 2383 | 0.120 |
Why?
|
| Nurses | 1 | 2016 | 75 | 0.120 |
Why?
|
| Anti-Anxiety Agents | 1 | 2015 | 70 | 0.110 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2019 | 321 | 0.110 |
Why?
|
| Hypnotics and Sedatives | 1 | 2015 | 133 | 0.110 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2021 | 674 | 0.110 |
Why?
|
| Psychopathology | 1 | 2014 | 31 | 0.100 |
Why?
|
| Aged | 4 | 2021 | 20897 | 0.100 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2016 | 126 | 0.100 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2014 | 97 | 0.100 |
Why?
|
| Tyrosine | 1 | 2014 | 144 | 0.100 |
Why?
|
| United States | 2 | 2021 | 11828 | 0.100 |
Why?
|
| Psychiatry | 1 | 2016 | 269 | 0.100 |
Why?
|
| Chi-Square Distribution | 2 | 2013 | 561 | 0.100 |
Why?
|
| Scotland | 1 | 2013 | 24 | 0.100 |
Why?
|
| Demography | 1 | 2014 | 238 | 0.100 |
Why?
|
| Germany | 1 | 2013 | 56 | 0.100 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2015 | 265 | 0.100 |
Why?
|
| Interleukin-10 | 1 | 2014 | 186 | 0.100 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2014 | 193 | 0.100 |
Why?
|
| Diastole | 1 | 2013 | 178 | 0.090 |
Why?
|
| Seasonal Affective Disorder | 1 | 2012 | 4 | 0.090 |
Why?
|
| Risk Assessment | 1 | 2021 | 3691 | 0.090 |
Why?
|
| Phototherapy | 1 | 2012 | 37 | 0.090 |
Why?
|
| Models, Theoretical | 1 | 2014 | 363 | 0.090 |
Why?
|
| Reading | 1 | 2012 | 75 | 0.080 |
Why?
|
| Adolescent | 4 | 2014 | 20734 | 0.080 |
Why?
|
| Hypolipidemic Agents | 1 | 2013 | 194 | 0.080 |
Why?
|
| Attitude of Health Personnel | 1 | 2016 | 700 | 0.080 |
Why?
|
| Up-Regulation | 1 | 2013 | 833 | 0.080 |
Why?
|
| Seasons | 1 | 2012 | 333 | 0.080 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2016 | 906 | 0.080 |
Why?
|
| Cholesterol | 1 | 2013 | 541 | 0.080 |
Why?
|
| Physicians | 1 | 2016 | 634 | 0.080 |
Why?
|
| Oxidative Stress | 1 | 2014 | 798 | 0.080 |
Why?
|
| Antihypertensive Agents | 1 | 2013 | 420 | 0.080 |
Why?
|
| Emergency Service, Hospital | 1 | 2018 | 1203 | 0.080 |
Why?
|
| Brain | 2 | 2021 | 3188 | 0.080 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 1380 | 0.080 |
Why?
|
| Blood Pressure | 1 | 2013 | 1337 | 0.060 |
Why?
|
| Depressive Disorder | 1 | 2010 | 457 | 0.060 |
Why?
|
| Risk Factors | 4 | 2016 | 10983 | 0.060 |
Why?
|
| Internship and Residency | 1 | 2016 | 1212 | 0.060 |
Why?
|
| Age Factors | 1 | 2013 | 2836 | 0.060 |
Why?
|
| Logistic Models | 1 | 2010 | 1806 | 0.060 |
Why?
|
| Retrospective Studies | 3 | 2019 | 17633 | 0.060 |
Why?
|
| Severity of Illness Index | 1 | 2013 | 3030 | 0.050 |
Why?
|
| Statistics as Topic | 2 | 2014 | 239 | 0.050 |
Why?
|
| Prospective Studies | 1 | 2013 | 6445 | 0.040 |
Why?
|
| Analysis of Variance | 2 | 2014 | 938 | 0.040 |
Why?
|
| Animals | 1 | 2021 | 33909 | 0.040 |
Why?
|
| Central Nervous System | 1 | 2021 | 277 | 0.040 |
Why?
|
| Psychiatric Nursing | 1 | 2016 | 7 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2018 | 313 | 0.030 |
Why?
|
| Benzodiazepines | 1 | 2015 | 104 | 0.030 |
Why?
|
| Malondialdehyde | 1 | 2014 | 49 | 0.030 |
Why?
|
| Glutathione Peroxidase | 1 | 2014 | 48 | 0.030 |
Why?
|
| Catalase | 1 | 2014 | 63 | 0.030 |
Why?
|
| Inpatients | 1 | 2019 | 549 | 0.030 |
Why?
|
| Syndrome | 1 | 2017 | 1160 | 0.030 |
Why?
|
| Superoxide Dismutase | 1 | 2014 | 176 | 0.030 |
Why?
|
| Models, Statistical | 1 | 2016 | 482 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 783 | 0.020 |
Why?
|
| Eye Movements | 1 | 2012 | 64 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 1891 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 427 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 1250 | 0.020 |
Why?
|
| Hospitalization | 1 | 2018 | 1927 | 0.020 |
Why?
|
| Prevalence | 1 | 2016 | 2683 | 0.020 |
Why?
|
| Circadian Rhythm | 1 | 2012 | 315 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2018 | 5083 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2012 | 1231 | 0.020 |
Why?
|
| Mass Screening | 1 | 2012 | 807 | 0.020 |
Why?
|
| Mental Disorders | 1 | 2012 | 890 | 0.010 |
Why?
|
| Pregnancy | 1 | 2016 | 7427 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2012 | 4013 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2012 | 12853 | 0.010 |
Why?
|